OmniSonics Medical Technologies
OmniSonics Medical Technologies is a U.S.-based medical device company founded in 1998 that developed devices for treating vascular occlusive diseases. The private, venture-backed firm historically operated from Lakewood with 51-100 employees.
- Company typePrivate
- Founded1998
- HeadquartersLakewood, United States
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What OmniSonics Medical Technologies does
OmniSonics Medical Technologies was a U.S.-based medical device company founded in 1998 and headquartered in Lakewood, United States. Per firmographic data, the company developed medical devices used in the treatment of vascular occlusive diseases, an end-market suggesting catheter-based or ultrasound-based thrombectomy technology for clot removal in peripheral or deep venous applications.
The company operated as a private, venture-backed entity with 51-100 employees. Across four documented funding rounds between 2000 and 2007, OmniSonics raised approximately $89.7M in aggregate from a syndicate of notable medical device investors, including Canaan Partners, Domain Associates, General Electric Pension Trust, Hambrecht & Quist Capital Management, Johnson & Johnson Development Corporation, Mitsubishi International Corporation, New England Partners, Nomura International, and Prism Venture Management. The largest single round was a $43M Series 3 in October 2003, co-led by GE Pension Trust and Nomura International, indicating significant institutional confidence at the company's mid-stage. The most recent documented capital raise was a $20M round in July 2007.
The company's current operating status is uncertain. The primary domain, OmniSonics.com, is listed for sale on HugeDomains at $9,795, with the available source material limited to this domain listing page. No current product information, management team, revenue, customer base, or regulatory filings are documented in the input data, representing a significant evidence gap for any current operational assessment.
OmniSonics Medical Technologies firmographics
Firmographics- Name
- OmniSonics Medical Technologies
- Website
- https://omnisonics.com
- Company type
- Private
- Founded year
- 1998
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- OmniSonics Medical Technologies is a U.S.-based medical device company founded in 1998 that developed devices for treating vascular occlusive diseases. The private, venture-backed firm historically operated from Lakewood with 51-100 employees.
- Ownership category
- akta.pro rank
OmniSonics Medical Technologies industry classification
Industry- Product category
- Vascular Medical Devices
- NAICS
- Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Thrombectomy, Embolic Protection & Stroke Intervention Devices (HLAHAFAJ)
- akta.pro secondary industry
- Vascular Access & Closure Devices (Sheaths, Guidewires, Closure Systems) (HLAHAFAK)
Keywords
Where OmniSonics Medical Technologies is headquartered
LocationHeadquarters
- HQ city
- Lakewood
- HQ country
- United States
- HQ region
- North America
Markets served
OmniSonics Medical Technologies business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales
OmniSonics Medical Technologies product offering
Product offeringCore offering
OmniSonics Medical Technologies develops and manufactures medical devices used in the treatment of vascular occlusive diseases. The company focuses on an ultrasound-based catheter technology platform designed to address blocked or occluded blood vessels. Its offerings are intended for healthcare providers, including hospitals and vascular intervention specialists.
Differentiator
Problem solved
Functional benefit
Products and services
- Ultrasonic vascular occlusion treatment devices Medical devices that use ultrasound-based catheter technology to treat vascular occlusive diseases, intended for use by vascular surgeons and interventional specialists in hospital settings.
Companies that use OmniSonics Medical Technologies
Customer profileIdeal customer profiles1 record
OmniSonics Medical Technologies technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
OmniSonics Medical Technologies partnerships and signals
Strategic signalRecent moves5 records
Expansion highlights2 records
OmniSonics Medical Technologies competitors and assessment
Company assessmentDirect peers
- Penumbra Inc. Penumbra is a leading developer of thrombectomy and aspiration systems for venous, arterial, and neurovascular occlusions. It is the most directly comparable peer, addressing the same vascular occlusive disease indications that OmniSonics targeted.
- Inari Medical: Inari Medical develops catheter-based thrombectomy devices (FlowTriever, ClotTriever) for venous thromboembolism and peripheral applications. It competes directly in the same vascular occlusion treatment category as OmniSonics' historical focus.
- AngioDynamics: AngioDynamics develops and markets peripheral vascular devices including thrombectomy catheters (e.g., AngioVac). It is a direct peer in the vascular occlusive disease treatment market, though typically smaller scale than top-tier peers.
Broad incumbents
- Stryker (Neurovascular): Stryker's Neurovascular business (built largely around the former Concentric Medical acquisition) offers stent retrievers and aspiration devices for stroke intervention. It is a broad incumbent with overlapping thrombectomy capabilities for vascular occlusion.
- Medtronic: Medtronic operates a broad vascular and neurovascular portfolio including thrombectomy and embolic protection devices. As a diversified incumbent, it competes in the same disease space as OmniSonics but across many other categories as well.
- Boston Scientific: Boston Scientific's peripheral interventions and neurology franchises include vascular access, thrombectomy, and embolic protection products. It is a broad incumbent with overlapping vascular occlusion device capabilities.
- Teleflex: Teleflex offers vascular access and interventional products used in similar procedural contexts as OmniSonics' devices. It is a broader incumbent operating across multiple vascular and surgical device categories.
- Abbott (Vascular): Abbott's vascular franchise includes devices for peripheral and coronary intervention, including embolic protection. As a diversified medical device incumbent, it competes in adjacent vascular occlusion applications.
- Terumo (Interventional Systems): Terumo's interventional systems business includes guidewires, catheters, and access devices used in vascular occlusion procedures. It is a broad incumbent with overlapping procedural product lines.
Emerging players
- Surmodics: Surmodics develops drug-coated balloon and thrombectomy technologies for peripheral vascular disease. It is an emerging player with meaningful but narrower overlap to OmniSonics' historical vascular occlusion focus.
Market position
Strengths2 records
Weaknesses3 records
Competitive moat2 records
Key risks4 records
Key highlights4 records
Customer concentration
OmniSonics Medical Technologies social profiles
Digital presenceOmniSonics Medical Technologies financial estimates
Financial estimateRevenue estimate
Valuation estimate
OmniSonics Medical Technologies leadership team
Management profileNumber of profiles
OmniSonics Medical Technologies funding detail
Funding detailFunding overview
Funding rounds4 records
Investors9 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
OmniSonics Medical Technologies M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about OmniSonics Medical Technologies
What does OmniSonics Medical Technologies do?
OmniSonics Medical Technologies develops and manufactures medical devices used in the treatment of vascular occlusive diseases. The company focuses on an ultrasound-based catheter technology platform designed to address blocked or occluded blood vessels. Its offerings are intended for healthcare providers, including hospitals and vascular intervention specialists.
When was OmniSonics Medical Technologies founded?
OmniSonics Medical Technologies was founded in 1998. It employs 51 to 100 people.
Where is OmniSonics Medical Technologies based?
OmniSonics Medical Technologies is headquartered in Lakewood, United States, in the North America region.
Who are OmniSonics Medical Technologies's main competitors?
Direct peers on record are Penumbra Inc., Inari Medical and AngioDynamics. Broad incumbents are Stryker (Neurovascular), Medtronic, Boston Scientific, Teleflex, Abbott (Vascular) and Terumo (Interventional Systems). Surmodics is listed as an emerging player.
Does OmniSonics Medical Technologies have an API?
No public API is recorded for OmniSonics Medical Technologies.
What industry is OmniSonics Medical Technologies in?
OmniSonics Medical Technologies's product category is Vascular Medical Devices. Its primary akta.pro industry code is HLAHAFAJ, Thrombectomy, Embolic Protection & Stroke Intervention Devices, with a secondary code of HLAHAFAK, Vascular Access & Closure Devices (Sheaths, Guidewires, Closure Systems). Its NAICS code is 339112 and its SIC code is 3841.